Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 13
Review
Deconstructing ADAURA. It is Not Yet Time to Forgo Platinum-based Adjuvant Chemotherapy in Resected Early Stage (IB-IIIA) EGFR-mutant NSCLC
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,364 | Dovepress* | 6,014+ | 322 | 6,336 | |
| PubMed Central* | 350 | 155 | 505 | ||
| Totals | 6,364 | 477 | 6,841 | ||
| *Since 19 May 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 1 | 1 | 2 |
View citations on PubMed Central and Google Scholar